May 14 |
3 Must-Have Penny Stocks to Boost Your 2024 Portfolio
|
May 7 |
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
|
Apr 25 |
Vistagen reports positive results for mental fatigue treatment
|
Apr 25 |
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
|
Apr 24 |
Vistagen Therapeutics: A Pipeline With Potential In Anxiety And Depression
|
Apr 19 |
7 Stocks Under $15 Predicted to Boom in the Next 2 Years
|
Apr 9 |
Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027
|
Apr 9 |
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
|
Apr 1 |
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
|
Mar 26 |
30 Countries with the Lowest Depression Rates
|